YERXA BENJAMIN R 4

What Happened

• Benjamin R. Yerxa, President and Director of Opus Genetics (IRD), sold 7,470 shares on 2026-04-23. The weighted average sale price was $5.24 per share, for total proceeds of approximately $39,121. This was a sale (disposition), not a purchase.

Key Details

• Transaction date: 2026-04-23; Form 4 filed: 2026-04-27 (timely).
• Price: weighted average $5.24; shares sold in multiple transactions at prices ranging $5.2314–$5.2413 (per footnote).
• Reason/footnote: Sold automatically to satisfy tax withholding obligations arising from vesting and settlement of a restricted stock unit (RSU) award — non‑discretionary (Footnote F1).
• Footnote F2: Reporting person can provide breakdown of how many shares were sold at each price within the stated range.
• Shares owned after the transaction: not provided in the excerpt of the filing.

Context

• Because the sale was an automatic withholding to cover taxes on RSU vesting (rather than a discretionary open‑market sell for investment reasons), it is generally considered routine and less indicative of the insider’s view on the company’s prospects.